Rilzabrutinib, a potent and selective Bruton?s tyrosine kinase inhibitor, suppresses reactive oxygen species production and CD11b activation in human eosinophils - Vienna 2024

Knowing your ABCs of airways disease: advances, biomarkers and control

Chair(s): Robert Snelgrove, Clarice Lim

Session type: Oral presentation

Rilzabrutinib, a potent and selective Bruton?s tyrosine kinase inhibitor, suppresses reactive oxygen species production and CD11b activation in human eosinophils

Kai-Ting Shade

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Metabolomic endo-phenotypes based on eicosanoids of 15-lipooxygenase pathway in AERD

Adam St?pie?

Replay

Poster

Abstract

Slides

Some middle age biomarkers can identify impaired lifetime lung function trajectories: a prospective study from 1st to 6th decade

Dinh Bui

Replay

Abstract

Slides

COPD patients display pronounced changes of IL-33 and ST2 expression in alveolar capillary phenotypes

Cecilia Andersson

Replay

Poster

Abstract

Slides

LSC - 2024 - Multiplex protein quantification per cell type in bronchoalveolar lavage cytospin cells of patients with asthma and healthy individuals

Ellen Tufvesson

Replay

Abstract

Slides

A comparative analyses of group 2 innate lymphoid cells in sputum from patients with non-asthmatic eosinophilic bronchitis and allergic asthma

Takahiro Matsuyama

Replay

Poster

Abstract

Slides

Sputum proteomics shows association between asthma duration and NETosis

P Jane Mcdowell

Replay

Poster

Abstract

Slides

Prevalence and impact of eosinophilic degranulation in patients with severe asthma

Nanna Dyhre-petersen

Poster

Abstract

Slides

Sensitisation to Staphylococcus aureus enterotoxin a marker of an autoimmune phenotype of severe asthma?

Freja Lajer

Replay

Abstract

Slides

Rilzabrutinib, a potent and selective Brutons tyrosine kinase inhibitor, suppresses reactive oxygen species production and CD11b activation in human eosinophils

Kai-ting Shade

Replay

Poster

Abstract

Slides

Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma

Michael Fricker

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}